Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
Jing Chen(Sun Yat-sen University), Limin Zheng(Sun Yat-sen University)
Cited by 101
Related Papers
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|183
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma
|British Journal of Cancer|2018|127
Cholinergic macrophages promote the resolution of peritoneal inflammation
|Proceedings of the National Academy of Sciences|2024|14